Plus   Neg

Stock Alert: Haemonetics Corporation Down 8%

Shares of healthcare company, providing hematology products and solutions, Haemonetics Corporation (HAE) are down more than 8% Tuesday morning at $80.01. It has traded in the range of $63.41- $140.36 in the past one year.

The company said the pandemic has significantly impacted its first-quarter financial results.

The company reported first-quarter adjusted EPS of $0.46 per share, down 43.2% from last year, but beat the average estimate of analysts polled by Thomson Reuters at $0.41 per share.

Revenue for the quarter decreased 18% to $196 million. The consensus estimate was at $198.27 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT